|
Status |
Public on Apr 08, 2016 |
Title |
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
Recent evidence suggests that leflunomide, a DHODH inhibitor, disrupts neural crest development and melanoma pathogenesis via inhibiting transcription elongation. Here, we provide evidence that a transcriptional regulator, HEXIM1, is upregulated in response to leflunomide. HEXIM1 is assembled into the 7SK snRNP complex to sequester and inhibit the kinase P-TEFb. P-TEFb triggers elongation by phosphorylating RNA polymerase II and pausing factors. Knockdown of hexim in zebrafish rescues the effects of leflunomide. HEXIM1 expression is low in human melanoma. In addition, HEXIM1 overexpression can suppress melanoma onset in zebrafish. Increased HEXIM1 expression, in response to low nucleotides triggered by DHODH inhibition, sequesters P-TEFb away from melanoma pathogenesis, proliferation and cell cycle genes based on GRO-seq and ChIP-seq analyses. This reduces productive elongation at genes that maintain the tumorigenic state. Our study illustrates that HEXIM1 is a tumor suppressor that responds to cell stress, consequently inhibiting productive elongation of proliferative genes in melanoma.
|
|
|
Overall design |
2 DMSO control, 2 Leflunomide treated and 2 A771726 treated replicates.
|
|
|
Contributor(s) |
Tan JL, Saint-André V, Yang S, Greer CB, Kim YJ, Kim TH, Young RA, Zon LI |
Citation missing |
Has this study been published? Please login to update or notify GEO. |
Submission date |
May 08, 2014 |
Last update date |
May 15, 2019 |
Contact name |
Leonard Zon |
E-mail(s) |
zon@enders.tch.harvard.edu
|
Organization name |
Boston Children's Hospital
|
Department |
Oncology/Hematology
|
Street address |
1 Blackfan Circle
|
City |
Boston |
State/province |
MA |
ZIP/Postal code |
02115 |
Country |
USA |
|
|
Platforms (1) |
GPL11154 |
Illumina HiSeq 2000 (Homo sapiens) |
|
Samples (6)
|
GSM1382433 |
48h DMSO treated A375 cells replicate a |
GSM1382434 |
48h DMSO treated A375 cells replicate b |
GSM1382435 |
48h Leflunomide treated A375 cells replicate a |
GSM1382436 |
48h Leflunomide treated A375 cells replicate b |
GSM1382437 |
48h A771726 treated A375 cells replicate a |
GSM1382438 |
48h A771726 treated A375 cells replicate b |
|
This SubSeries is part of SuperSeries: |
GSE57432 |
HEXIM1 is induced by DHODH inhibition to suppress melanoma |
|
Relations |
BioProject |
PRJNA246459 |
SRA |
SRP041793 |